Ngā hua rapu

Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. mā Daniel J. O’Shannessy, Gordon H. Yu, Robert Smale, Yao‐Shi Fu, Sunil Singhal, Robert Thiel, Elizabeth B. Somers, Anil Vachani

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer mā Ryan Hutchinson, Richard Adams, Darragh G. McArt, Manuel Salto‐Tellez, Bharat Jasani, Peter W. Hamilton

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer mā Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

Whiwhi kuputuhi katoa

Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma mā Michael T. Tetzlaff, Penvadee Pattanaprichakul, Jennifer A. Wargo, Patricia S. Fox, Keyur P. Patel, Jeannelyn S. Estrella, Russell R. Broaddus, Michelle D. Williams, Michael A. Davies, Mark J. Routbort, Alexander J. Lazar, Scott E. Woodman, Wen-Jen Hwu, Jeffrey E. Gershenwald, Víctor G. Prieto, Carlos A. Torres‐Cabala, Jonathan L. Curry

Whiwhi kuputuhi katoa

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer mā Fiona Day, Andrea Murányi, Shalini Singh, Kandavel Shanmugam, David S. Williams, David J. Byrne, Kym Pham, Michelle Palmieri, Jeanne Tie, Thomas M. Grogan, Peter Gibbs, Oliver M. Sieber, Paul Waring, Jayesh Desai

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects mā Dana eOlsen, Jan Trøst eJørgensen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

HER2 testing in gastric cancer: a practical approach mā Josef Rüschoff, Wedad Hanna, Michael Bilous, Manfred Hofmann, R. Yoshiyuki Osamura, Frédérique Penault‐Llorca, Marc J. van de Vijver, Giuseppe Viale

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance mā Manfred Dietel, Korinna Jöhrens, Mv Laffert, Michael Hummel, Hendrik Bläker, Berit Müller, Annika Lehmann, Carsten Denkert, Frank L. Heppner, A Koch, Christine Sers, I. Anagnostopoulos

Whiwhi kuputuhi katoa

Suggested Guidelines for Immunohistochemical Techniques in Veterinary Diagnostic Laboratories mā José A. Ramos‐Vara, Matti Kiupel, Timothy V. Baszler, Laura Bliven, Bruce W. Brodersen, Brian J. Chelack, Keith West, Stefanie Czub, Fábio Del Piero, Sharon M. Dial, E. J. Ehrhart, Tanya Graham, Lisa Manning, Daniel Paulsen, V. E. Valli

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib mā Fernando López‐Ríos, Bárbara Angulo, Belen Gomez, Debbie Mair, Rebeca Martínez, Esther Conde, Felice Shieh, Jeffrey Vaks, Rachel Langland, H. Jeffrey Lawrence, David González de Castro

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action mā Volker Heinemann, Jean‐Yves Douillard, Michel Ducreux, Marc Peeters

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The current and future state of companion diagnostics mā Amit Agarwal, Glenn Snyder, Dan Ressler

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey mā Yasushi Yatabe, Keith M. Kerr, Ahmad Utomo, Pathmanathan Rajadurai, Văn Khanh Trần, Xiang Du, Teh‐Ying Chou, Ma. Luisa D. Enriquez, Geon Kook Lee, Jabed Iqbal, Shanop Shuangshoti, Jin-Haeng Chung, Koichi Hagiwara, Zhiyong Liang, Nicola Normanno, Keunchil Park, Shinichi Toyooka, Chun‐Ming Tsai, Paul Waring, Li Zhang, Rose McCormack, M. Ratcliffe, Y. Itoh, Masatoshi Sugeno, Tony Mok

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers mā Stephen Yip, A. John Iafrate, David N. Louis

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Companion diagnostics: the key to personalized medicine mā Jan Trøst Jørgensen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Specificity of HercepTest in Determining <i>HER-2</i>/<i>neu</i> Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System mā Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji, Melissa J. Barnes, Stuart J. Schnitt

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer mā David Parkinson, Robert McCormack, Susan M. Keating, Steven Gutman, Stanley R. Hamilton, Elizabeth Mansfield, Margaret Piper, Patricia A. Deverka, Felix W. Frueh, J. Milburn Jessup, Lisa M. McShane, Sean Tunis, Caroline C. Sigman, Gary J. Kelloff

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Molecular Pathology of Breast Cancer mā Kimberly H. Allison

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluator... mā Murry W. Wynes, Lynette M. Sholl, Manfred Dietel, Ed Schuuring, Ming‐Sound Tsao, Yasushi Yatabe, Raymond R. Tubbs, Fred R. Hirsch

Whiwhi kuputuhi katoa

<i>Epidermal Growth Factor Receptor</i>Mutation Testing in the Care of Lung Cancer Patients mā Lecia V. Sequist, Victoria A. Joshi, Pasi A. Jänne, Daphne W. Bell, Panos Fidias, Neal I. Lindeman, David N. Louis, Jeffrey C. Lee, Eugene J. Mark, Janina Longtine, Peter C. Verlander, Raju Kucherlapati, Matthew Meyerson, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa